99% up GMP DMF Carn...

99% up GMP DMF Carnitine orotate 32543-38-7
99% up GMP DMF Carnitine orotate 32543-38-7
99% up GMP DMF Carnitine orotate 32543-38-7
99% up GMP DMF Carnitine orotate 32543-38-7
99% up GMP DMF Carnitine orotate 32543-38-7

99% up GMP DMF Carnitine orotate 32543-38-7

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: 99%
  • Payment Terms : L/C,D/A,D/P,T/T

Keywords

Carnitine orotate Carnitine orotate

Quick Details

  • Appearance:White or almost white hygroscopic powder
  • Application:API
  • PackAge:25kg per drum
  • ProductionCapacity:1000|Kilogram|Month
  • Storage:Normal temperature
  • Transportation:normal temperature.

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier . 

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

 

Details:

Name

Carnitine orotate

EINECS N/A
CAS No. 32543-38-7 Density N/A
PSA 132.15000 LogP -2.56520
Solubility N/A Melting Point 191 °C
Formula C7H16NO3.C5H3N2O4 Boiling Point N/A
Molecular Weight 333.34 Flash Point N/A
Transport Information N/A Appearance N/A
Safety   Risk Codes N/A
Molecular Structure Molecular Structure of 32543-38-7 (1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, 1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylate (1:1)) Hazard Symbols N/A
Synonyms

DL-Carnitine Orotate;3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium 1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid salt;(3-Carboxy-2-hydroxypropyl)trimethylammonium orotate;

 

 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View